Genotype of Primary GIST Predicts OutcomeGenotype of Primary GIST Predicts Outcome

The genotype of primary gastrointestinal stromal tumors (GIST) of gastric origin can be used to predict the risk of relapse and, thereby, identify patients for adjuvant therapy with imatinib, according to an analysis of a European database. Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news